Phase III Study of L-Cysteine in Patients With Erythropoietic Protoporphyria
Status:
Completed
Trial end date:
2001-09-01
Target enrollment:
Participant gender:
Summary
OBJECTIVES:
I. Determine the long-term efficacy and safety of L-cysteine in the prevention
photosensitivity in patients with erythropoietic protoporphyria.